Brief: Lineage Cell Therapeutics Presents New Opregen Data
14/10/2019 23:19
Oct 14 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS PRESENTS NEW OPREGEN® DATA AT
AMERICAN
ACADEMY OF OPHTHALMOLOGY ANNUAL MEETING
* TREATMENT WITH OPREGEN CONTINUES TO BE WELL TOLERATED
Source text for Eikon: ID:nBw6fBTJTa
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million